Pharmaco - Press Releases

Date	Title	Company
01-Sep-2021	AEVIS VICTORIA SA - Half-year results 2021 - AEVIS returns to profitability in the first semester of 2021 - Revenues and EBITDA up compared to 2020	AEVIS VICTORIA SA
31-Aug-2021	PharmaSGP Group completes acquisition of OTC brand portfolio (Baldriparan(R), Formigran(R), Spalt(R) and Kamol(R)) from GSK	PharmaSGP Holding SE
31-Aug-2021	Meridian Bioscience, Inc.: Meridian Bioscience to Present at the H. C. Wainwright 23rd Annual Global Investment Conference	Meridian Bioscience, Inc.
31-Aug-2021	Community Wellness Announces COVID Home Management Program	Community Wellness
31-Aug-2021	Real-world evidence demonstrates significant difference in fracture	Theramex
31-Aug-2021	Immutep announces Chinese patent grant for LAG-3 antagonist antibody LAG525	Immutep
31-Aug-2021	Platforms Launches packaged end-to-end solution for NGS laboratories with Sentieon to accelerate adoption of NGS testing	BC Platforms (BCP)
31-Aug-2021	New Data on finerenone for the protection of patients with chronic kidney disease and type 2 diabetes from cardiovascular events and kidney disease progression	Bayer
31-Aug-2021	TISSIUM Raises €50M in Series C Financing to Propel its Platform to Commercial Stage	TISSIUM
31-Aug-2021	Advanced Biological Laboratories Receives CE-IVD Registration for its UltraGene Assay SARS-CoV-2 452R & 484K & 484Q Mutations	Advanced Biological Laboratories (ABL)
31-Aug-2021	LEXICON WELCOMES NEW ESC HEART FAILURE TREATMENT GUIDELINES ESTABLISHING SGLT INHIBITORS AS STANDARD OF CARE	Lexicon Pharmaceuticals, Inc.
31-Aug-2021	Novo Holdings participates in US$65.7 Million Series C Financing in Singapore-based Regional Telehealth Platform Doctor Anywhere	Novo Holdings
31-Aug-2021	Biocomposites to present data on STIMULAN® and genex® at American Academy of Orthopaedic Surgeons Annual Meeting	Biocomposites
31-Aug-2021	Vifor Pharma’s Ferinject® granted new recommendations in updated 2021 ESC heart failure guidelines	Vifor Pharma
31-Aug-2021	Late-Breaking Data Shows Abbott's Amplatzer™ Amulet™ Occluder Offers Superior Left Atrial Appendage Closure Compared to Watchman‡ Device for People With Atrial Fibrillation at Risk of Stroke	Abbott
31-Aug-2021	Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004	Bone Therapeutics
31-Aug-2021	International Health Partners joins with Orion Pharma	International Health Partners (IHP)
31-Aug-2021	CureVac-Studie: Präklinische Daten zeigen deutliche Verminderung von Leberfibrose mit mRNA-Therapeutikum	CureVac
31-Aug-2021	PAION AG: HANA PHARM RECEIVES MARKET APPROVAL FOR BYFAVO (REMIMAZOLAM) IN PROCEDURAL SEDATION IN SOUTH KOREA	PAION AG
31-Aug-2021	DEFENCE THERAPEUTICS FILES ACID-BASED HYDROGELS USA PROVISIONAL PATENT APPLICATION	Defence Therapeutics Inc.